Atrial fibrillation in therapeutic practice
Abstract
Atrial fibrillation (AF) in the practice of the therapist began to occur more often. Changed approaches to managing patients with AF. Triggers of the development of AF are inflammation and fibrosis in the myocardium, which are caused by the activation of RAAS and the transforming growth factor (TGF-β). In the arsenal of the doctor for treatment for AF there are new opportunities – it is radiofrequency ablation (RFA). Guidelines of the management of a patient with AF (ESC 2016) on the clearly defines the sequence of the doctor's actions in the treatment of a patient with AF.
References
1. Camm, A. J., Kirchhof P., Lip G. Y. H., et al. Guidelines for the management of atrial fibrillation. The TaskForce for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369–2429.
2. Сулимов, В. А., Голицин В. П., Панченко Е. П. и др. Диагностика и лечение фибрилляции предсердий. Рекомендации РКО, ВНОА, АССХ. Москва, 2013.
3. Kirchhof, P., S. Benussi, Dipak Kotecha et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European heart journal, 2016.
4. Stewart, S., Hart C. L., Hole D. J., McMurray J. J. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/ Paisley study. Heart 2001; 86: 516–521.
5. Go, A. S., Hylek E. M., Phillips K. A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370–2375.
Review
For citations:
Bova A.A. Atrial fibrillation in therapeutic practice. Military Medicine. 2018;(1):6-9. (In Russ.)
Views:
66
JATS XML
Email this article 